Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2022 08:05 ET | Source: Dream Finders Homes, Inc.

Dream Finders Homes Releases Investor Relations Presentation

JACKSONVILLE, Fla., June 17, 2022 (GLOBE NEWSWIRE) -- Dream Finders Homes, Inc. (the “Company”, “Dream Finders” or “DFH”) (NASDAQ: DFH), one of the nation’s fastest-growing companies, announced...
June 17, 2022 08:01 ET | Source: The Vita Coco Company

The Vita Coco Company Announces CFO Transition

NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today...
June 17, 2022 08:00 ET | Source: VYNE Therapeutics Inc.

VYNE Therapeutics Completes Enrollment in Phase 2a Trial of FMX114 for the Treatment of Mild-to-Moderate Atopic Dermatitis

BRIDGEWATER, N.J., June 17, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and...
June 17, 2022 08:00 ET | Source: Codexis, Inc.

Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides

Collaboration with Merck published in Science magazine REDWOOD CITY, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the...
June 17, 2022 08:00 ET | Source: DZS

DZS Chief Strategy Officer to Moderate Panel on $42B Broadband Equity, Access and Deployment (BEAD) Program at TIA Virtual Member Meeting and Global Conference 2022

DALLAS, June 17, 2022 (GLOBE NEWSWIRE) -- DZS (Nasdaq: DZSI), a global leader in access networking infrastructure, service assurance and consumer experience software solutions, today announced that...
June 17, 2022 08:00 ET | Source: Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics Announces CY6463 Data Demonstrating Improved Cellular Energetics in Preclinical Models of Mitochondrial Disease

CY6463 alleviated mitochondrial dysfunction and reduced inflammation in preclinical models of mitochondrial complex 1 deficiency Data provide support for ongoing CY6463 clinical studies in CNS...
June 17, 2022 07:45 ET | Source: Draganfly Inc

Draganfly to be Featured on Bloomberg on The RedChip Money Report® June 18th

Los Angeles, CA., June 17, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and...
June 17, 2022 07:30 ET | Source: Whole Earth Brands

Whole Earth Brands, Inc. Increases Revolving Credit Facility to $125 Million

CHICAGO, June 17, 2022 (GLOBE NEWSWIRE) -- Whole Earth Brands, Inc. (the “Company”) (Nasdaq: FREE) a global food company enabling healthier lifestyles through premium plant-based sweeteners, flavor...
June 17, 2022 07:30 ET | Source: Altimmune, Inc

Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022

GAITHERSBURG, Md., June 17, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Medical Director,...
June 17, 2022 07:30 ET | Source: Cytokinetics, Incorporated

Cytokinetics Provides Regulatory Update for Omecamtiv Mecarbil

SOUTH SAN FRANCISCO, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that, in response to a request from the U.S. Food and Drug Administration...